Recruiting
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
NCT07680946
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- TG Therapeutics Investigational Trial Site Little Rock, Arkansas, United States
- TG Therapeutics Investigational Trial Site Richardson, Texas, United States